To continue reading this article, sign up for FREE to
Membership is FREE
and provides you with
instant access
to email newsletters, digital publications, our full content catalogue & more...
Already have an account?
BioFocus DPI Enhances High-Throughput Screening Library
Read time: Less than a minute
BioFocus DPI, a leading provider of gene-to-drug candidate discovery services, announces that it has added 350,000 new compounds to its diverse screening library. Through these additional compounds, BioFocus DPI’s high-throughput screening platform now includes more than 900,000 compounds.
The 350,000 new compounds were selected to complement BioFocus DPI’s existing diverse screening library. By applying stringent lead-likeness criteria in its selection process, BioFocus DPI has enhanced the quality and diversity of its high-throughput screening library, offering a broader chemical space for customers’ hit finding campaigns.
“Combined with an extensive range of knowledge-based methodologies, this updated screening library allows BioFocus DPI customers to select optimal screening sets for their hit finding campaigns,” said Kate Hilyard, VP Biological Sciences. “This improved screening set, combined with leading-edge target class and assay development expertise, translates into one of the most powerful screening platforms in the industry.”
The 350,000 new compounds were selected to complement BioFocus DPI’s existing diverse screening library. By applying stringent lead-likeness criteria in its selection process, BioFocus DPI has enhanced the quality and diversity of its high-throughput screening library, offering a broader chemical space for customers’ hit finding campaigns.
“Combined with an extensive range of knowledge-based methodologies, this updated screening library allows BioFocus DPI customers to select optimal screening sets for their hit finding campaigns,” said Kate Hilyard, VP Biological Sciences. “This improved screening set, combined with leading-edge target class and assay development expertise, translates into one of the most powerful screening platforms in the industry.”
